We conclude that several signature components identified in our cancer dataset analysis are highly embryonic enriched, expressed at sites of active tissue remodeling in vivo during embryonic mammary development and in many Brca1-/- mammary tumors. The gene discussed is BRCA1; the disease is cancer.